Sbir phase II: a new approach for isolating leukocyte sub-populations to enable efficient manufacturing of cellular therapies
Ended Project Grant Awarded Last action
- Award ID
- 1951153
- Recipient
-
Halcyon Biomedical Inc. UEI C15ACBHQ4P67
- Awarding agency
-
National Science Foundation
- Obligated
- $948,852
Award facts
- Assistance listing
- 47.041 Engineering
- Completion date
- Originally
- Funding agency
- Division of Industrial Innovation National Science Foundation
- Place of performance
- Houston, TX 77204, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $50,000 | |
| Amendment | $0 | |
| Amendment | $149,452 | |
| Original award | $749,400 |
Quick answers
Who received award 1951153?
1951153 was awarded to Halcyon Biomedical Inc. by National Science Foundation on May 1, 2020.
How much is award 1951153 worth?
$948,852 has been obligated on 1951153.
Which agency awarded 1951153?
National Science Foundation awarded 1951153, with funding from Division of Industrial Innovation (National Science Foundation).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award